Loans, overdrafts and long-term debt



(in millions)	November 3, 2018			February 3, 2018			October 28, 2017
Debt:
Senior unsecured notes due 2024, net of unamortized discount	$	399.0		$	398.9		$	398.9
Senior unsecured term loan	303.9			326.2			332.9
Revolving credit facility	282.0			—			256.0
Bank overdrafts	4.1			14.2			8.3
Total debt	$	989.0		$	739.3		$	996.1
Less: Current portion of loans and overdrafts	(322.6		)	(44.0		)	(291.8		)
Less: Unamortized capitalized debt issuance fees	(6.0		)	(7.1		)	(7.5		)
Total long-term debt	$	660.4		$	688.2		$	696.8

Revolving credit facility and term loan (the “Credit Facility”)

The Company’s Credit Facility contains a $700 million senior unsecured multi-currency multi-year revolving credit facility and a $357.5 million senior unsecured term loan facility. The maturity date for the Credit Facility, including both individual facilities disclosed above, is July 2021.

Deferred financing fees associated with the revolving credit facility as of November 3, 2018 total $2.6 million with the unamortized balance recorded as an asset within the condensed consolidated balance sheets. Accumulated amortization related to these capitalized fees as of November 3, 2018 was $1.5 million (February 3, 2018 and October 28, 2017: $1.2 million and $1.1 million, respectively). Amortization relating to these fees of $0.1 million and $0.3 million was recorded as interest expense in the condensed consolidated income statements for the 13 and 39 weeks ended November 3, 2018, respectively ($0.1 million and $0.3 million for the 13 and 39 weeks ended October 28, 2017, respectively). As of November 3, 2018, February 3, 2018 and October 28, 2017, the Company had stand-by letters of credit outstanding of $14.6 million, $15.7 million and $15.7 million, respectively, that reduce remaining borrowing availability. The revolving credit facility had a weighted average interest rate of 3.62% and 2.45% during the 39 weeks ended November 3, 2018 and October 28, 2017, respectively.

Deferred financing fees associated with the term loan facility as of November 3, 2018 total $6.2 million with the unamortized balance recorded as a direct deduction from the outstanding liability within the condensed consolidated balance sheets. Accumulated amortization related to these capitalized fees as of November 3, 2018 was $4.1 million (February 3, 2018 and October 28, 2017: $3.5 million and $3.3 million, respectively). Amortization relating to these fees of $0.2 million and $0.6 million was recorded as interest expense in the condensed consolidated income statements for the 13 and 39 weeks ended November 3, 2018, respectively ($0.2 million and $0.6 million for the 13 and 39 weeks ended October 28, 2017, respectively). Excluding the impact of the interest rate swap designated as a cash flow hedge discussed in Note 16, the term loan had a weighted average interest rate of 3.44% and 2.34% during the 39 weeks ended November 3, 2018 and October 28, 2017, respectively.

Senior unsecured notes due 2024

On May 19, 2014, Signet UK Finance plc (“Signet UK Finance”), a wholly owned subsidiary of the Company, issued $400 million aggregate principal amount of its 4.70% senior unsecured notes due in 2024 (the “Notes”). The Notes were issued under an effective registration statement previously filed with the SEC. The Notes are jointly and severally guaranteed, on a full and unconditional basis, by the Company and by certain of the Company’s wholly owned subsidiaries (such subsidiaries, the “Guarantors”). See Note 22 for additional information.

Deferred financing fees relating to the senior unsecured notes total $7.0 million. Accumulated amortization related to these capitalized fees as of November 3, 2018 was $3.1 million (February 3, 2018 and October 28, 2017: $2.6 million and $2.4 million, respectively). The remaining unamortized capitalized fees are recorded as a direct deduction from the outstanding liability within the condensed consolidated balance sheets. Amortization relating to these fees of $0.2 million and $0.5 million was recorded as interest expense in the condensed consolidated income statements for the 13 and 39 weeks ended November 3, 2018, respectively ($0.2 million and $0.5 million for the 13 and 39 weeks ended October 28, 2017, respectively).

Other

As of November 3, 2018, February 3, 2018 and October 28, 2017, the Company was in compliance with all debt covenants.